Which are the causes of Lichen Planus?

The exact cause of Lichen Planus remains unknown, but it is widely considered to be a chronic inflammatory condition where the immune system mistakenly attacks the skin or mucous membranes.

Understanding the Mechanism

Think of the immune system in Lichen Planus as a security force that has become overactive. Instead of protecting the body from external threats, it begins to target the basal cells of the epidermis. This autoimmune response is triggered by a complex interplay between genetic predisposition and environmental factors, though the specific "spark" that initiates this reaction is often difficult to pinpoint for any single patient.

Genetic and Environmental Factors

While there is no single "Lichen Planus gene," research suggests that certain human leukocyte antigen (HLA) types may make some individuals more susceptible to developing the condition. This means your genetics might set the stage, but environmental triggers often play the lead role in starting the process. Potential triggers include:

• Medications: Reactions to drugs used for high blood pressure, heart disease, or arthritis.


• Infections: Chronic hepatitis C infection is frequently associated with the development of Lichen Planus.


• Contact Allergens: Exposure to certain metals (like those in dental fillings) or chemicals can sometimes provoke an immune response.

Causes vs. Risk Factors

In medical research, we distinguish between a cause (the direct mechanism that creates the disease) and a risk factor (a condition that increases the likelihood of the disease appearing). For Lichen Planus, we have identified many risk factors, such as viral infections or specific stressors, but the underlying "cause"—why the immune system decides to attack the skin in the first place—is still a subject of intense investigation.

Current Research

Current research is focused on identifying the specific autoantigens that the immune system is targeting. By mapping these molecular interactions, we hope to move toward targeted therapies that calm the immune system without suppressing it entirely. Until these mechanisms are fully understood, treatment remains focused on managing inflammation and symptoms.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)